Collectively, these results suggested that DHA and EPA interventions promote GLUT4 translocation and restore glucose homeostasis in skeletal muscle, manifesting a therapeutic potential for improving hyperglycemia. The gene discussed is SLC2A4; the disease is Hyperglycemia.